Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer

by Lehnert, M., Thuerlimann, B., Mross, K., Kroeger, N., Schueller, J., Kupper, H.
Published 2014

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer

by Lehnert, M., Mross, K., Schueller, J., Thuerlimann, B., Kroeger, N., Kupper, H.
Published 2016

First-in-human phase i study of PRS-050 (Angiocal), an anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors

by Mross K., Richly H., Fischer R., Scharr D., Büchert M., Stern A., Gille H., Audoly L.P., Scheulen M.E.
Published 2019